Bone Strength
8
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
Role of Estrogen on Skeletal Outcomes in FHA
Vitamin D Intervention in Infants - 6 Years Follow-up (VIDI2)
Normative Database for HR-pQCT-Based Radius and Tibia Strength
Vibration Intervention For Bone Enhancement In Childhood Cancer Survivors
The Influence of High Impact Exercise on Musculoskeletal Health in Older Men
The Impact of a Structured Physical Activity Program on Bone Strength and Psycho-Motor Learning of Young Children
Bone Geometry, Strength, and Biomechanical Changes in Runners With a History of Stress Fractures